As a leading N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate supplier, we deliver high-quality products across diverse grades to meet evolving needs, empowering global customers with safe, efficient, and compliant chemical solutions.
What is the chemical structure of N- (2- (diethylamino) ethyl) -5- ((Z) - (5-fluoro-1, 2-dihydro-2-oxo-3H-indol-3-ylidene) methyl) -2, 4-dimethyl-1H-pyrrole-3-carboxamide (2S) -hydroxybutanedioate?
This is a rather complex nomenclature for organic compounds. To clarify its chemical structure, it is necessary to analyze it in detail according to the nomenclature of organic chemistry. "N- (2- (diethylamino) ethyl) -5 - ((Z) - (5-fluoro-1,2-dihydro-2-oxo-3H-indole-3-subunit) methyl) -2,4-dimethyl-1H-pyrrole-3-formamide (2S) -hydroxysuccinate".
First looking at the main structure, "1H-pyrrole-3-formamide" determines that its core is a pyrrole ring, which is connected to a formamide group at the 3rd position. "2,4-dimethyl" indicates that the 2nd and 4th positions of the pyrrole ring are connected to a methyl group. "N - (2 - (diethylamino) ethyl) " shows that the nitrogen atom of the formamide group is connected to a 2- (diethylamino) ethyl group.
Furthermore, "5- ((Z) - (5-fluoro-1,2-dihydro-2-oxo-3H-indole-3-subunit) methyl) ", which means that the pyrrole ring is connected to a specific substituent at the 5-position, which is connected by a double bond of the (Z) configuration, with 5-fluoro-1,2-dihydro-2-oxo-3H-indole-3-subunit at one end and methyl at the other end.
Finally, " (2S) -hydroxysuccinate" indicates that this compound is an ester of hydroxysuccinic acid in the (2S) configuration.
In summary, the structure of this compound is composed of pyrrole ring as the core, with a variety of complex substituents, and esters with hydroxysuccinic acid in a specific configuration. Through such disassembly and analysis, its chemical structure was gradually clarified.
What are the main uses of N- (2- (diethylamino) ethyl) -5- ((Z) - (5-fluoro-1, 2-dihydro-2-oxo-3H-indol-3-ylidene) methyl) -2, 4-dimethyl-1H-pyrrole-3-carboxamide (2S) -hydroxybutanedioate?
This is a chemical substance named N- (2- (diethylamino) ethyl) -5- ((Z) - (5-fluoro-1,2-dihydro-2-oxo-3H-indole-3-subunit) methyl) -2,4-dimethyl-1H-pyrrole-3-formamide (2S) -hydroxysuccinate. However, the specific use of this substance requires detailed study of classics and research before it can be obtained.
As far as I know, chemical substances have a wide range of uses. Or in the field of medicine, it can be used as a key ingredient in the development of new drugs. With its unique chemical structure and characteristics, it can target the pathological mechanism of specific diseases and exert therapeutic effects, such as inhibiting the growth of pathogens and regulating the physiological functions of the body. Or in the field of materials science, help develop new functional materials, improve material properties, make them more stable and conductive, etc., to meet various needs.
However, because I do not know the details, there is no exact literature support, and it is difficult to determine its exact use. To understand its use, it is necessary to seek experts in chemistry, medicine and other fields, or to carefully review cutting-edge research literature and professional materials, in order to accurately grasp the main uses of this chemical substance and help the development of related fields.
What are the safety and side effects of N- (2- (diethylamino) ethyl) -5- ((Z) - (5-fluoro-1, 2-dihydro-2-oxo-3H-indol-3-ylidene) methyl) -2, 4-dimethyl-1H-pyrrole-3-carboxamide (2S) -hydroxybutanedioate?
N- (2- (diethylamino) ethyl) -5- ((Z) - (5-fluoro-1,2-dihydro-2-oxo-3H-indole-3-subunit) methyl) -2,4-dimethyl-1H-pyrrole-3-formamide (2S) -hydroxysuccinate. The safety and side effects of this drug are related to the health of patients and cannot be ignored.
In terms of safety, its mechanism of action in the human body is quite complex. When using it for the first time, doctors need to carefully observe the patient's physique, because there may be individual differences and different tolerances to the drug. For those with this kind of drug, at the beginning of the clinical trial, some patients did not feel obvious discomfort, and the various indicators of the body also became stable, which seems to prove that its safety is acceptable. However, it should not be careless. The safety of long-term use still needs more time and cases to prove.
When it comes to its side effects, it should not be underestimated. Some patients feel dizzy after taking it, as if they are in clouds and fog, which may affect the blood supply or nerve conduction to the brain due to the drug. There are also patients with digestive system disturbance, loss of appetite, and epigastric discomfort, which seems to be poor in the abdomen. And there are also signs of skin allergies, erythema itching, like worms walking on the skin, which are all signs of drug side effects. Therefore, when taking medication, doctors should pay close attention to the patient's reaction and weigh the pros and cons, so that patients can take medication to cure the disease, but also to ensure safety and avoid side effects.
What is the market outlook for N- (2- (diethylamino) ethyl) -5- ((Z) - (5-fluoro-1, 2-dihydro-2-oxo-3H-indol-3-ylidene) methyl) -2, 4-dimethyl-1H-pyrrole-3-carboxamide (2S) -hydroxybutanedioate?
The name of this drug is long and complex, and according to its characteristics, it must be a new or specific-purpose compound. Looking at the current market, if this compound has not been widely used, or because it is in the research and development stage, its prospects are still unknown.
Covers the development of new drugs, from the laboratory to the clinic, and then to the market, the journey is long and difficult. Many drugs under development may fail in the middle due to poor efficacy and questionable safety. If this compound has passed rigorous clinical trials and proved its efficacy and high safety, it is expected to emerge in the field of treatment of corresponding diseases.
Taking anticancer drugs as an example, if new compounds can accurately act on specific targets of cancer cells and have small side effects, they will be favored by the pharmaceutical market. However, its market prospects are also restricted by many factors, such as the number and pros and cons of competing drugs, the difficulty of production and preparation of this compound, the cost, and whether it is covered by medical insurance policies.
If there are many competing products and the efficacy is equivalent, it may be difficult for this compound to occupy a place in the market without outstanding advantages. Furthermore, if the production process is complicated and the cost is high, it will also limit its marketing activities. Only by overcoming many difficulties and meeting the market demand, can this "N- (2- (diethylamino) ethyl) -5- ((Z) - (5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene) methyl) -2, 4-dimethyl-1H-pyrrole-3-carboxamide (2S) -hydroxybutanedioate" have a bright market prospect, bring good news to patients, and leave a strong impression in the field of medicine.
What are the production processes of N- (2- (diethylamino) ethyl) -5- ((Z) - (5-fluoro-1, 2-dihydro-2-oxo-3H-indol-3-ylidene) methyl) -2, 4-dimethyl-1H-pyrrole-3-carboxamide (2S) -hydroxybutanedioate?
This compound is a rather complex organic substance, and its production process involves several key steps.
First, the raw materials are prepared, and various starting materials required for the synthesis of the compound need to be carefully prepared, such as indoles containing specific substituents, pyrrole derivatives, and amine compounds with specific structures. The purity and quality of the raw materials have a significant impact on the subsequent reaction results.
Then it is synthesized as a key intermediate. Through a series of organic chemical reactions, such as condensation reactions, substitution reactions, etc., the raw materials interact to build a molecular skeleton. In this process, the reaction conditions, such as temperature, reaction time, and reactant ratio, need to be precisely controlled to ensure that the reaction proceeds according to the predetermined path and improve the yield and purity of key intermediates. For example, through clever regulation of the reaction conditions, (Z) - (5-fluoro-1,2-dihydro-2-oxo-3H-indole-3-subunit) methyl and pyrrole derivatives are smoothly condensed.
Furthermore, the amide reaction is a specific amine compound that reacts with a carboxyl-containing intermediate to form an amide bond to construct the main structure of the target compound. This step also requires fine regulation of the reaction parameters to ensure that the amidation reaction is carried out fully and efficiently, while avoiding the occurrence of side reactions.
Finally, a salt-forming reaction is performed, in which the host compound reacts with (2S) -hydroxysuccinic acid to form the target salt compound. After the reaction is completed, it still needs to be separated, purified and other post-treatment processes, such as column chromatography, recrystallization and other means to obtain high-purity N- (2 - (diethylamino) ethyl) -5- ((Z) - (5 - fluoro - 1,2 - dihydro - 2 - oxo - 3H - indole - 3 - isyl) methyl) - 2,4 - dimethyl - 1H - pyrrole - 3 - formamide (2S) - hydroxysuccinate.
The entire production process is like a delicate chemical "dance", with each step closely interlocked. Minor differences in reaction conditions may have a significant impact on product quality and yield. Producers need to have deep organic chemistry knowledge and rich practical experience in order to achieve efficient and stable production.